Medtronic Medical Surgical — Research and development expense decreased by 3.9% to $174.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 6.1%, from $164.00M to $174.00M.
Higher spending indicates a focus on future growth and innovation, while lower spending may signal cost-cutting or a mature product cycle.
Represents the costs incurred by the Medical Surgical segment for research, design, and development of new medical devic...
Standard R&D expense reported by medical device peers like Stryker or Boston Scientific.
mdt_segment_medical_surgical_research_and_development_expense| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $135.75M | $135.75M | $135.75M | $135.75M | $162.00M | $171.00M | $164.00M | $185.00M | $169.00M | $181.00M | $174.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +19.3% | +5.6% | -4.1% | +12.8% | -8.6% | +7.1% | -3.9% |
| YoY Change | — | — | — | — | +19.3% | +26.0% | — | — | +4.3% | +5.8% | +6.1% |